Losartan Potassium Tablet, Film Coated
Product Images NDC 68084-348

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68084-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Carton

Losartan Potassium 100 mg tablets, USP, film-coated oral tablets. The label shows a package containing 100 tablets (10 x 10), marked Rx Only. It includes storage instructions and dispensing information, distributed by American Health Packaging, Columbus, Ohio.*

FDA Label Image

25 mg Carton

Losartan Potassium 25 mg tablets, USP, film coated, oral dosage form. The label indicates a package of 100 tablets (10 x 10) by American Health Packaging. It includes storage instructions, safety warnings, dispensing information for pharmacists, and details about the drug product manufacturer, Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

50 mg Carton

Packaging label for Losartan Potassium tablets, USP, 50 mg strength. The label states the quantity as 100 tablets (10 x 10) and includes standard prescribing cautions. Distributed by American Health Packaging, Columbus, Ohio. Barcode and NDC 68084-347-01 are visible.*

FDA Label Image

7c74ee11 5813 39cd E053 2a91aa0a5d6c

Losartan Potassium film-coated tablets shown in white, oval shape with imprint codes 'Z' on one side and '2' on the other side. The image includes a millimeter scale for size reference. No strength or package information is visible in the image.*

FDA Label Image

7c74ee11 5814 39cd E053 2a91aa0a5d6c

Losartan Potassium film-coated tablet, white, capsule-shaped with the imprint 'Z 16' on one side. The image shows both the front with the imprint and the plain back side. The tablet is measured against a millimeter scale for size reference.*

FDA Label Image

7c74f89a 87e8 1073 E053 2991aa0ae062

Close-up image of a white, oblong, film-coated tablet of Losartan Potassium with the imprint code 'Z 18' on one side. The other side is plain without markings. A millimeter scale is visible alongside the tablets to indicate size.*

FDA Label Image

Losapotatab2 (883ed688 Efe0 4aa1 B10f E658bd32b498 02)

A line graph comparing the percentage of patients with the primary endpoint over study months for Atenolol (dashed line) and Losartan Potassium (solid line). The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients from 0 to 16%. A note below the graph indicates an adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Losapotatab3 (883ed688 Efe0 4aa1 B10f E658bd32b498 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months for Losartan Potassium and Atenolol. The solid line represents Losartan Potassium, showing a consistently lower percentage of stroke patients compared to the dashed line for Atenolol. The graph includes a noted adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Losapotatab (883ed688 Efe0 4aa1 B10f E658bd32b498 04)

A comparative hazard ratio forest plot chart showing Losartan-K versus Atenolol event rates related to Primary Composite events and Stroke (fatal/non-fatal) outcomes. The chart stratifies data by patient subgroups including age, gender, race, ischemic heart disease (ISH), diabetes, and history of cardiovascular disease (CVD) with hazard ratios and 95% confidence intervals plotted to indicate relative risk favoring either Losartan-K or Atenolol.*

FDA Label Image

Losapotatab5 (883ed688 Efe0 4aa1 B10f E658bd32b498 05)

A line graph comparing the percentage of patients with an event over 48 months for Losartan Potassium Tablet versus placebo. The solid line represents Losartan Potassium, the dotted line represents placebo, showing a risk reduction of 16.1% with a p-value of 0.022.*

FDA Label Image

Image 01

Chemical structure of Losartan Potassium showing its molecular components and arrangement, including rings with nitrogen atoms, a chlorine substituent, and a potassium ion.*

FDA Label Image

Image 03

This image shows a sheet of multiple identical labels for Losartan Potassium 25 mg tablets, film-coated, by American Health Packaging. Each label includes the product name, strength, dosage form, a barcode, lot number, and expiration date placeholders. The labels are intended for human prescription drug packaging.*

FDA Label Image

Image 05

This image shows multiple identical labels for Losartan Potassium 50 mg film-coated tablets. Each label includes the drug name and strength, a barcode, placeholder text for lot number and expiration date, and the labeler information identifying American Health Packaging, Columbus, Ohio.*

FDA Label Image

Image 07

Losartan Potassium 100 mg film-coated tablet labels by American Health Packaging. Each label displays the product name, strength, dosage form, a barcode, placeholders for expiry date and lot number, and the manufacturer details. Labels are arranged in pairs with consistent layout and text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.